Patient-controlled sedation using remimazolam during third molar extraction: a case report
10.17245/jdapm.2024.24.1.75
- Author:
Kyung Nam PARK
1
;
Myong-Hwan KARM
;
Kwang-Suk SEO
;
Hyun Jeong KIM
;
Seung-Hwa RYOO
Author Information
1. Department of Dental Anesthesiology, School of Dentistry, Seoul National University, Seoul, Republic of Korea
- Publication Type:Case Report
- From:Journal of Dental Anesthesia and Pain Medicine
2024;24(1):75-80
- CountryRepublic of Korea
- Language:English
-
Abstract:
Dental sedation plays a pivotal role in alleviating patient anxiety during various procedures. Remimazolam, a benzodiazepine derivative, stands out for its distinctive attributes, particularly its rapid onset of sedation coupled with a brief duration, making it an invaluable option for dental applications. The patient was admitted for the extraction of impacted third molars via patient-controlled sedation and not only demonstrated stable vital signs but also expressed a high level of satisfaction with the procedure. An in-depth analysis of plasma remimazolam concentrations and changes in the Patient State Index revealed negative correlation patterns, highlighting the inherent potential of remimazolam in achieving effective sedation. This expanded research scope aims to provide a more nuanced understanding of the pharmacological responses to remimazolam in dental sedation scenarios.This case report offers valuable insights into the evolving landscape of dental sedation methodologies and paves the way for a more informed and evidence-based approach to the use of remimazolam in patient-controlled sedation.
